Aaron Davis

Mr. Aaron I.
Davis is a Chief Executive Officer at Boxer Capital Management LLC, an Executive Chairman at CiVi Biopharma Holdings, Inc., a Chief Executive Officer at Boxer Capital Management LLC /Private Equity/ and a Chief Executive Officer at MVA Investors LLC.
He is on the Board of Directors at CiVi Biopharma, Inc., Flare Therapeutics, Inc. and Tango Therapeutics Sub, Inc. Mr. Davis was previously employed as an Independent Director by Rain Oncology, Inc., a Chairman & Chief Executive Officer by BCTG Acquisition Corp., an Independent Director by Tango Therapeutics, Inc., an Independent Director by iTeos Therapeutics, Inc., an Independent Director by Mirati Therapeutics, Inc., an Independent Director by Odonate, Inc., a Vice President by Tavistock Life Sciences Co., a Portfolio Manager by Tavistock Group, Inc. (United States), and a Principal by UBS Securities LLC.
He also served on the board at Sojournix, Inc. and Kalypsys, Inc. He received his undergraduate degree from Emory University and a graduate degree from The Trustees of Columbia University in The City of New York.